Biotech

All Articles

' Medical intuitiveness' led FDA experts to back Zevra's rare illness med

.Zevra Rehabs' rare illness medicine seems to be to become on the road to permission this fall after...

Pfizer takes $230M attacked after axing failed DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has actually gone a $230 ...

AC Immune finds 'landmark' prospective in Alzheimer's medicine data

.After much more than twenty years of work with neurodegenerative health conditions, Swiss biotech h...

GSK falls ph. 2 HPV vaccination over absence of best-in-class potential

.GSK has ditched a phase 2 individual papillomavirus (HPV) injection from its pipeline after determi...

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.Operating system Therapies are going to specify on the NYSE American inventory substitution this mo...

ALX's fizzling CD47 action rate sends out inventory spiraling down

.ALX Oncology's period 2 stomach cancer action price has actually deteriorated. After seeing its CD4...

Ionis axes eye illness from aim ats of Roche-partnered possibility after records disappoint

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of re...

Biogen's CEO mentioned no unsafe handle 2023. He prepares to become bold

.While Biogen's pharma peers are actually hunting for late-stage resources with little bit of danger...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Bio has actually been actually a biotech seeking a pipeline after it junked its own lead ass...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned liberties to a very early Alzheimer's illness plan to Denali Rehabs, g...